Résumé
Après avoir reçu pendant 21 jours une injection quotidienne de 250 mg/kg nicotinamide, des souris ont été examinées chroniquement par l'EEG. La nicotinamide prolonge la phase de sommeil et fait augmenter les mouvements oculaires.
Literatur
J. R. Smythies andW. F. Bridgers, Fedn. Proc.31, 530 (1972).
J. M. Beaton, Doctoral Dissertation, University of Alabama in Birmingham (1973).
H. Van Twyver, Physiol. Behav.4, 901 (1969).
T. Weiss andE. Rolden, Experientia20, 280 (1964).
J. Pagel, G. V. Pegram, S. Vaughn, P. Donaldson andW. F. Bridgers, Behav. Biol.9, 383 (1973).
G. V. Pegram, D. Hammond andW. F. Bridgers, Behav. Biol.9, 377 (1973).
M. Lipton, Med. Wld. News, Psychiatry, 41 (1973).
J. R. Smythies, Lancet, 1450 (1973).
A. Hoffer,Niacin Therapy in Schizophrenia (C. C. Thomas, Springfield, Illinois 1962).
R. J. Wyatt, B. A. Termini andJ. Davis, Schizophrenia Bull.4, 10 (1971).
T. A. Ban, H. E. Lehmann andA. Klingner, Int. J. clin. Pharmac. Ther. Tox.7, 44 (1973).
R. J. Baldessarini, Biochem. Pharmac.15, 741 (1966).
R. Tissot, Progr. Brain Res.18, 175 (1965).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Beaton, J.M., Pegram, G.V., Smythies, J.R. et al. The effects of nicotinamide on mouse sleep. Experientia 30, 926–927 (1974). https://doi.org/10.1007/BF01938366
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF01938366